Molecular basis of the VHL hereditary cancer syndrome
The DOI matches its Crossref record; 145 of the 146 references it cites were found in a registry or an index.
Abstract
The von Hippel-Lindau hereditary cancer syndrome was first described about 100 years ago. The unusual clinical features of this disorder predicted a role for the von Hippel-Lindau gene (VHL) in the oxygen-sensing pathway. Indeed, recent studies of this gene have helped to decipher how cells sense changes in oxygen availability, and have revealed a previously unappreciated role of prolyl hydroxylation in intracellular signalling. These studies, in turn, are laying the foundation for the treatment of a diverse set of disorders, including cancer, myocardial infarction and stroke.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the PHDs utilize ␣-ketoglutarate as a cosubstrate and require ferrous iron (Fe 2ϩ ) and ascorbate as cofactors (Kaelin, 2002;Schofield and Zhang, 1999).”
From Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase (2005) · cites this paper as Kaelin, 2002
In the citing paper
“Since pVHL binding to the ODD domain is dependent on PHD activity (Kaelin, 2002;Safran and Kaelin, 2003)”
From Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase (2005) · cites this paper as Kaelin, 2002
Citations
Cites
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“The interaction of pVHL with HIF-α is governed by the enzymatic hydroxylation of conserved proline residues that are located within highly conserved, peptidic, pVHL-binding domains within the HIF-α subunit”
BackgroundEpstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914
Mutations of the VHL tumour suppressor gene in renal carcinoma
Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-85 · Cited by 1,730
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Self-citation
Research works printed but not linked: 5
- Collins, E. T. Intra-ocular growths (two cases, brother and sister, with peculiar vascular new growth, probably retinal, affecting both eyes). Trans. Ophthalmol. Soc. UK 14, 141–149 (1894).
- Clifford, S., Prowse, A., Affara, N., Buys, C. & Maher, E. Inactivation of the von Hippel–Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Genes Chromosom. Cancer 22, 200–209 (1998). · DOI · Paper page
- Gallou, C. et al. Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC. Hum. Mutat. 13, 464–475 (1999). · DOI
- Ivan, M. et al. Biochemical purification and pharmacological inhibition of a mammalian HIF prolyl hydroxylase. Proc. Natl Acad. Sci. USA (in the press).
- Aiello, L. et al. Rapid and durable recovery of visual function in a patient with von Hippel–Lindau syndrome and optic nerve head hemangioma following systemic treatment with the VEGF receptor inhibitor SU5416. Ophthalmology (in the press).
Cited by
Items 101–200 of 864
Esteban, M. A., Harten, S. K., Tran, M. G., & Maxwell, P. H. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006020181 · Cited by 161
Shuin, T., Yamasaki, I., Tamura, K., Okuda, H., Furihata, M., & Ashida, S. (2006) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyl052 · Cited by 159
New Syndrome of Paraganglioma and Somatostatinoma Associated With Polycythemia
Pacak, K., Jochmanova, I., Prodanov, T., Yang, C., Merino, M. J., Fojo, T., Prchal, J. T., Tischler, A. S., Lechan, R. M., & Zhuang, Z. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.1912 · Cited by 157
Regulation of Hypoxia Inducible Factors (HIF) in Hypoxia and Normoxia During Placental Development
Patel, J., Landers, K., Mortimer, R. H., & Richard, K. (2010) · Placenta · doi:10.1016/j.placenta.2010.08.008 · Cited by 157
Chen, C., Sun, X., Guo, P., Dong, X.-Y., Sethi, P., Cheng, X., Zhou, J., Ling, J., Simons, J. W., Lingrel, J. B., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506183200 · Cited by 156
Niu, X., Zhang, T., Liao, L., Zhou, L., Lindner, D. J., Zhou, M., Rini, B., Yan, Q., & Yang, H. (2012) · Oncogene · doi:10.1038/onc.2011.266 · Cited by 155
HIF-1: master and commander of the hypoxic world
Mazure, N. M., Brahimi-Horn, M. C., Berta, M., Benizri, E. I., Bilton, R. L., Dayan, F., Ginouvès, A., Berra, E., & Pouysségur, J. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.04.022 · Cited by 181
Lassau, N., Chami, L., Benatsou, B., PERONNEAU, P., & Roche, A. J. (2007) · European Radiology Supplements · doi:10.1007/s10406-007-0233-6 · Cited by 151
Lee, K., Kang, J. E., Park, S.-K., Jin, Y., Chung, K.-S., Kim, H.-M., Lee, K., Kang, M. R., Lee, M. K., Song, K. B., et al. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.018 · Cited by 149
Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis
Wang, S.-S., Gu, Y.-F., Wolff, N., Stefanius, K., Christie, A., Dey, A., Hammer, R. E., Xie, X.-J., Rakheja, D., Pedrosa, I., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414789111 · Cited by 147
Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice
Albers, J., Rajski, M., Schönenberger, D., Harlander, S., Schraml, P., von Teichman, A., Georgiev, S., Wild, P. J., Moch, H., Krek, W., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202231 · Cited by 147
Lei, L., Mason, S., Liu, D., Huang, Y., Marks, C., Hickey, R., Jovin, I. S., Pypaert, M., Johnson, R. S., & Giordano, F. J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01580-07 · Cited by 147
Bishop, T., Lau, K. W., Epstein, A. C. R., Kim, S. K., Jiang, M., O'Rourke, D., Pugh, C. W., Gleadle, J. M., Taylor, M. S., Hodgkin, J., et al. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020289 · Cited by 145
Immunohistochemistry in Undifferentiated Neoplasm/Tumor of Uncertain Origin
Lin, F., & Liu, H. (2014) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2014-0061-ra · Cited by 144
The von Hippel–Lindau Chuvash mutation promotes pulmonary hypertension and fibrosis in mice
Hickey, M. M., Richardson, T., Wang, T., Mosqueira, M., Arguiri, E., Yu, H., Yu, Q.-C., Solomides, C. C., Morrisey, E. E., Khurana, T. S., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci36362 · Cited by 141
Effects of hypoxia on tumor metabolism
Kim, J., Gao, P., & Dang, C. V. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9060-4 · Cited by 166
Rankin, E. B., Higgins, D. F., Walisser, J. A., Johnson, R. S., Bradfield, C. A., & Haase, V. H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.8.3163-3172.2005 · Cited by 139
Wang, Y., Roche, O., Xu, C., Moriyama, E. H., Heir, P., Chung, J., Roos, F. C., Chen, Y., Finak, G., Milosevic, M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112129109 · Cited by 137
Feng, S., Shen, Y., Sullivan, J. A., Rubio, V., Xiong, Y., Sun, T.-P., & Deng, X. W. (2004) · The Plant Cell · doi:10.1105/tpc.021949 · Cited by 135
Molecular aspects of renal cell carcinoma: a review.
Koul, H. K., Huh, J., Rove, K. O., Crompton, L., Koul, S., Meacham, R. B., & Kim, F. J. (2011) · American Journal of Cancer Research · Cited by 157
E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis
Jung, C., Hwang, K., Yoo, J., Cho, W.-K., Kim, J., Kim, W. H., & Im, D. (2006) · Nature Medicine · doi:10.1038/nm1440 · Cited by 155
Neurologic Manifestations of von Hippel-Lindau Disease
Butman, J. A., Linehan, W. M., & Lonser, R. R. (2008) · JAMA · doi:10.1001/jama.300.11.1334 · Cited by 136
Pheochromocytoma: an update on genetics and management
Karagiannis, A. I., Mikhailidis, D. P., Athyros, V. G., & Harsoulis, F. (2007) · Endocrine Related Cancer · doi:10.1677/erc-07-0142 · Cited by 144
VHL and Hypoxia Signaling: Beyond HIF in Cancer
Zhang, J., & Zhang, Q. H. (2018) · Biomedicines · doi:10.3390/biomedicines6010035 · Cited by 141
HIF-1 in Cell Cycle Regulation, Apoptosis, and Tumor Progression
Goda, N., Dozier, S. J., & Johnson, R. S. (2003) · Antioxidants and Redox Signaling · doi:10.1089/152308603768295212 · Cited by 140
Linehan, W. M., & Zbar, B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.006 · Cited by 129
Role of angiogenesis on bone formation.
Portal‐Núñez, S., Lozano, D., & Esbrit, P. (2012) · PubMed · doi:10.14670/hh-27.559 · Cited by 147
Kurban, G., Hudon, V., Duplan, E., Ohh, M., & Pause, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2560 · Cited by 126
Richard, S., Graff, J., Lindau, J., & Resche, F. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15957-6 · Cited by 127
von Hippel-Lindau Tumor Suppressor Protein and Hypoxia-Inducible Factor in Kidney Cancer
Maynard, M. A., & Ohh, M. (2004) · American Journal of Nephrology · doi:10.1159/000075346 · Cited by 123
Liang Cheng, C., Zhang, S., MacLennan, G. T., Antonio Lopez-beltran, B., & Montironi, R. (2008) · Human Pathology · doi:10.1016/j.humpath.2008.09.009 · Cited by 135
Wong, W. T., Liang, K. J., Hammel, K., Coleman, H. R., & Chew, E. Y. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.04.033 · Cited by 125
Hypoxia-mediated Selective mRNA Translation by an Internal Ribosome Entry Site-independent Mechanism
Young, R. M., Wang, S.-J., Gordan, J. D., Ji, X., Liebhaber, S. A., & Simon, M. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710079200 · Cited by 121
Treatment of kidney cancer: Insights Provided by the VHL Tumor‐Suppressor Protein
Kaelin, W. G. (2009) · Cancer · doi:10.1002/cncr.24232 · Cited by 129
Self-citationTyrosine Phosphorylation Disrupts Elongin Interaction and Accelerates SOCS3 Degradation
Haan, S., Ferguson, P., Sommer, U., Hiremath, M., McVicar, D. W., Heinrich, P. C., Johnston, J. A., & Cacalano, N. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303170200 · Cited by 119
A Role for Hox A5 in Regulating Angiogenesis and Vascular Patterning
Rhoads, K. F., Arderiu, G., Charboneau, A. L., Hansen, S. L., Hoffman, W. Y., & Boudreau, N. J. (2005) · Lymphatic Research and Biology · doi:10.1089/lrb.2005.3.240 · Cited by 121
Mikhaylova, O., Ignacak, M. L., Barankiewicz, T. J., Harbaugh, S. V., Yi, Y., Maxwell, P. H., Schneider, M., Van Geyte, K., Carmeliet, P., Revelo, M. P., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01231-07 · Cited by 117
Influence of the RNA-Binding Protein HuR in pVHL-Regulated p53 Expression in Renal Carcinoma Cells
Galbán, S., Martindale, J. L., Mazan-Mamczarz, K., López de Silanes, I., Fan, J., Wang, W., Decker, J., & Gorospe, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7083-7095.2003 · Cited by 117
Von Hippel–Lindau: How a rare disease illuminates cancer biology
Richard, S., Gardie, B., Couvé, S., & Gad, S. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.05.005 · Cited by 131
Harada, H. (2016) · Journal of Radiation Research · doi:10.1093/jrr/rrw012 · Cited by 123
Regulation of Nrf2-Mediated Phase II Detoxification and Anti-oxidant Genes
Keum, Y. (2012) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2012.20.2.144 · Cited by 124
The magic of the hypoxia-signaling cascade
Benizri, E. I., Ginouvès, A., & Berra, E. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7472-0 · Cited by 147
Hickey, M. M., Lam, J. C., Bezman, N. A., Rathmell, W. K., & Simon, M. C. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32614 · Cited by 110
Vhlh Gene Deletion Induces Hif-1-Mediated Cell Death in Thymocytes
Biju, M. P., Neumann, A. K., Bensinger, S. J., Johnson, R. S., Turka, L. A., & Haase, V. H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.9038-9047.2004 · Cited by 110
TBK1 Is a Synthetic Lethal Target in Cancer with VHL Loss
Hu, L., Xie, H., Liu, X., Potjewyd, F., James, L. I., Wilkerson, E. M., Herring, L. E., Xie, L., Chen, X., Cabrera, J. C., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0837 · Cited by 108
Tumorigenic Mutations in VHL Disrupt Folding In Vivo by Interfering with Chaperonin Binding
Feldman, D. E., Spiess, C., Howard, D. E., & Frydman, J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00423-4 · Cited by 126
Li, L., Zhang, L., Zhang, X., Yan, Q., Minamishima, Y. A., Olumi, A. F., Mao, M., Bartz, S., & Kaelin, W. G. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00282-07 · Cited by 110
Self-citationLassau, N., Chebil, M., Chami, L., Bidault, S., Girard, E., & Roche, A. J. (2010) · Targeted Oncology · doi:10.1007/s11523-010-0136-7 · Cited by 105
Renal cell carcinoma for the nephrologist
Perazella, M. A., Dreicer, R., & Rosner, M. H. (2018) · Kidney International · doi:10.1016/j.kint.2018.01.023 · Cited by 109
Lau, K. W., Tian, Y.-M., Raval, R. R., Ratcliffe, P. J., & Pugh, C. W. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603675 · Cited by 104
Developmental arrest of angioblastic lineage initiates tumorigenesis in von Hippel-Lindau disease.
Vortmeyer, A. O., Frank, S., Jeong, S. Y., Yuan, K. C., Ikejiri, B. L., Lee, Y. S., Bhowmick, D. A., Lonser, R. R., Smith, R. D., Rodgers, G. P., et al. (2003) · PubMed · Cited by 104
Schley, G., Klanke, B., Schödel, J., Forstreuter, F., Shukla, D., Kurtz, A., Amann, K., Wiesener, M. S., Rosen, S., Eckardt, K.-U., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121249 · Cited by 103
The VHL Tumor Suppressor Gene: Insights into Oxygen Sensing and Cancer.
Kaelin, W. G. (2017) · Europe PMC (PubMed Central) · Cited by 130
Self-citationNew insights into an enigmatic tumour suppressor
Ratcliffe, P. J. (2003) · Nature Cell Biology · doi:10.1038/ncb0103-7 · Cited by 104
The road much traveled: trafficking in the cell nucleus
Gorski, S. A., Dundr, M., & Misteli, T. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.03.002 · Cited by 103
Von Hippel-Lindau Disease: Current Challenges and Future Prospects
Gläsker, S., Vergauwen, E., Koch, C. A., Kutikov, A., & Vortmeyer, A. O. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s190753 · Cited by 99
Current Pathology Keys of Renal Cell Carcinoma
Algaba, F., Akaza, H., López-Beltrán, A., Martignoni, G., Moch, H., Montironi, R., & Reuter, V. E. (2011) · European Urology · doi:10.1016/j.eururo.2011.06.047 · Cited by 117
A Role for von Hippel-Lindau Protein in Pancreatic β-Cell Function
Puri, S., Cano, D. A., & Hebrok, M. (2009) · Diabetes · doi:10.2337/db08-0749 · Cited by 97
Lenglet, M., Robriquet, F., Schwarz, K., Camps, C., Couturier, A., Hoogewijs, D., Buffet, A., Knight, S. J. L., Gad, S., Couvé, S., et al. (2018) · Blood · doi:10.1182/blood-2018-03-838235 · Cited by 107
Fu, X., Choi, E., Bubley, G. J., & Balk, S. P. (2004) · The Prostate · doi:10.1002/pros.20190 · Cited by 105
Tumor‐suppressive micro RNA ‐1291 directly regulates glucose transporter 1 in renal cell carcinoma
Yamasaki, T., Seki, N., Yoshino, H., Itesako, T., Yamada, Y., Tatarano, S., Hidaka, H., Yonezawa, T., Nakagawa, M., & Enokida, H. (2013) · Cancer Science · doi:10.1111/cas.12240 · Cited by 102
Liu, J., & Nussinov, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707401105 · Cited by 95
Peruzzi, B., Athauda, G., & Bottaro, D. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606850103 · Cited by 95
Radiogenomics in Renal Cancer Management—Current Evidence and Future Prospects
Ferro, M., Musi, G., Marchioni, M., Maggi, M., Veccia, A., Giudice, F. D., Barone, B., Crocetto, F., Lasorsa, F. M., Antonelli, A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054615 · Cited by 109
Two sides to every story: the HIF-dependent and HIF-independent functions of pVHL
Li, M., & Kim, W. Y. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01238.x · Cited by 109
Endocrine Pancreatic Tumors in von Hippel-Lindau Disease
Corcos, O., Couvelard, A., Giraud, S., Vullierme, M., O’Toole, D., Rebours, V., Stiévenart, J.-L., Penfornis, A., Niccoli, P., Baudin, É., et al. (2008) · Pancreas · doi:10.1097/mpa.0b013e31815f394a · Cited by 95
Reduced cilia frequencies in human renal cell carcinomas versus neighboring parenchymal tissue
Basten, S. G., Willekers, S., Vermaat, J. S. P., Slaats, G. G. G., Voest, E. E., van Diest, P. J., & Giles, R. H. (2013) · Cilia · doi:10.1186/2046-2530-2-2 · Cited by 101
Kurban, G., Duplan, E., Ramlal, N., Hudon, V., Sado, Y., Ninomiya, Y., & Pause, A. (2007) · Oncogene · doi:10.1038/sj.onc.1210709 · Cited by 108
Pheochromocytoma in Von Hippel-Lindau Disease
Hes, F. J., Höppener, J. W. M., & Lips, C. J. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021466 · Cited by 98
Hypoxia-dependent activation of HIF into a transcriptional regulator
Ruas, J. L., & Poellinger, L. (2005) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2005.04.001 · Cited by 102
When protein destruction runs amok, malignancy is on the loose
Pagano, M., & Benmaamar, R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00243-5 · Cited by 89
Asa, S. L. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.127 · Cited by 101
Regulation of ubiquitin ligase dynamics by the nucleolus
Mekhail, K., Khacho, M., Carrigan, A., Hache, R. R. J., Gunaratnam, L., & Lee, S. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200506030 · Cited by 102
Pseudohypoxic Pathways in Renal Cell Carcinoma
Bratslavsky, G., Sudarshan, S., Neckers, L., & Linehan, W. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2510 · Cited by 89
Insights into Cullin-RING E3 Ubiquitin Ligase Recruitment: Structure of the VHL-EloBC-Cul2 Complex
Nguyen, H. C., Yang, H., Fribourgh, J. L., Wolfe, L. S., & Xiong, Y. (2015) · Structure · doi:10.1016/j.str.2014.12.014 · Cited by 96
Nonrenal regulation of EPO synthesis
Weidemann, A., & Johnson, R. S. (2009) · Kidney International · doi:10.1038/ki.2008.687 · Cited by 98
pVHL Function Is Essential for Endothelial Extracellular Matrix Deposition
Tang, N., Mack, F. A., Haase, V. H., Simon, M. C., & Johnson, R. S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2519-2530.2006 · Cited by 102
Roberts, A. M., Watson, I. R., Evans, A. J., Foster, D. A., Irwin, M. S., & Ohh, M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1770 · Cited by 88
The Hypoxia-Inducible Factor and Tumor Progression Along the Angiogenic Pathway
Brahimi-Horn, M. C., & Pouysségur, J. (2004) · International review of cytology · doi:10.1016/s0074-7696(04)42004-x · Cited by 99
Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions
Gallou‐Kabani, C., Chauveau, D., Richard, S., Joly, D., Giraud, S., Olschwang, S., Martin, N., Saquet, C., Chrétien, Y., Méjean, A., et al. (2004) · Human Mutation · doi:10.1002/humu.20082 · Cited by 86
Lin, F., Shi, J., Liu, H., Hull, M. E., Dupree, W. B., Prichard, J., Brown, R. E., Zhang, J., Wang, H. L., & Schuerch, C. (2008) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31815701d1 · Cited by 85
Deubiquitylating enzymes and disease
Singhal, S., Taylor, M. C., & Baker, R. T. (2008) · BMC Biochemistry · doi:10.1186/1471-2091-9-s1-s3 · Cited by 93
Genetics and molecular pathogenesis of pheochromocytoma and paraganglioma
Galan, S., & Kann, P. H. (2012) · Clinical Endocrinology · doi:10.1111/cen.12071 · Cited by 92
Leiser, S. F., Fletcher, M., Begun, A., & Kaeberlein, M. (2013) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glt016 · Cited by 84
Hergovich, A., Lisztwan, J., Thoma, C. R., Wirbelauer, C., Barry, R. E., & Krek, W. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00232-06 · Cited by 84
Kobayashi, M., Morinibu, A., Koyasu, S., Gotö, Y., Hiraoka, M., & Harada, H. (2017) · FEBS Journal · doi:10.1111/febs.14280 · Cited by 86
Oncogenic aberrations of cullin-dependent ubiquitin ligases
Guardavaccaro, D., & Pagano, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207413 · Cited by 89
PHGDH as a Key Enzyme for Serine Biosynthesis in HIF2α-Targeting Therapy for Renal Cell Carcinoma
Yoshino, H., Nohata, N., Miyamoto, K., Yonemori, M., Sakaguchi, T., Sugita, S., Itesako, T., Kofuji, S., Nakagawa, M., Dahiya, R., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1589 · Cited by 95
Zhang, W. C., Wells, J. M., Chow, K.-H., Huang, H., Yuan, M., Saxena, T., Melnick, M. A., Politi, K. A., Asara, J. M., Costa, D. B., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0052-9 · Cited by 86
Galbán, S., Fan, J., Martindale, J. L., Cheadle, C., Hoffman, B., Woods, M. P., Temeles, G., Brieger, J., Decker, J., & Gorospe, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.7.2316-2328.2003 · Cited by 82
Hervouet, E. (2004) · Carcinogenesis · doi:10.1093/carcin/bgi001 · Cited by 82
Dahr, S. S., Cusick, M., Rodriguez-Coleman, H., Srivastava, S. K., Thompson, D. J. S., Linehan, W. M., Ferris, F. L., & Chew, E. Y. (2007) · Retina · doi:10.1097/iae.0b013e318030a290 · Cited by 81
Haase, V. H. (2005) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2005.03.006 · Cited by 89
microRNA-21 Governs TORC1 Activation in Renal Cancer Cell Proliferation and Invasion
Dey, N., Das, F., Ghosh‐Choudhury, N., Mandal, C. C., Parekh, D. J., Block, K. L., Kasinath, B. S., Abboud, H. E., & Choudhury, G. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037366 · Cited by 83
Harten, S. K., Shukla, D., Barod, R., Hergovich, A., Balda, M. S., Matter, K., Esteban, M. A., & Maxwell, P. H. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-06-0566 · Cited by 95
The structure and regulation of Cullin 2 based E3 ubiquitin ligases and their biological functions
Cai, W., & Yang, H. (2016) · Cell Division · doi:10.1186/s13008-016-0020-7 · Cited by 91
Corn, P. G., McDonald, E. R., Herman, J. G., & El‐Deiry, W. S. (2003) · Nature Genetics · doi:10.1038/ng1254 · Cited by 84
Zhou, J. R., Simon, J. M., Liao, C., Zhang, C., Hu, L., Zurlo, G., Liu, X., Fan, C., Hepperla, A. J., Jia, L., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.06.003 · Cited by 91
Ubiquitin ligases in cancer: Functions and clinical potentials
Duan, S., & Pagano, M. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.04.008 · Cited by 85
Radiological evaluation, management, and surveillance of renal masses in Von Hippel–Lindau disease
Meister, M. A., Choyke, P. L., Anderson, C., & Patel, U. (2008) · Clinical Radiology · doi:10.1016/j.crad.2008.10.010 · Cited by 76
Metadata
- Authors
- Kaelin, W. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Kaelin, William G.
- ORCID
- Kaelin, William G.
- Venue
- Nature Reviews Cancer
- Published
- 2002-09
- Volume
- 2
- Issue
- 9
- Pages
- 673-682
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2093776019
- Semantic Scholar
- 6b13bcf0623256d5dceb071144a84d45b84f9a99
- Cited by
- 865
- References
- 146
- Citations by year
- 2026: 18 · 2025: 29 · 2024: 25 · 2023: 21 · 2022: 24 · 2021: 25 · 2020: 34 · 2019: 32 · 2018: 28 · 2017: 22 · 2016: 27 · 2015: 29 · 2014: 39 · 2013: 42 · 2012: 46
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Keywords
- von Hippel-Lindau disease, VHL gene, hereditary cancer, oxygen sensing, prolyl hydroxylation, hypoxia signaling, tumour suppressor, cancer therapy
- MeSH terms
- Animals, von Hippel-Lindau Disease, Humans, Ligases, Neoplasms, Gene Expression Regulation, Neoplastic, Genetic Predisposition to Disease, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Von Hippel-Lindau Tumor Suppressor Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.